Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery

Biochimica et Biophysica Acta - General Subjects

Volumn 1860, Issue 8, 2016, Pages 1716-1727

  Gizaw, Solomon T ^a   Ohashi, Tetsu ^b   Tanaka, Masakazu ^b   Hinou, Hiroshi ^a,b   Nishimura, Shin Ichiro ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Hokkaido University and Medicinal Chemistry Pharmaceuticals LLC   (Japan)

Author keywords

Alzheimer's disease; Biomarker; Cerebrospinal fluid; Glycome; Human brain; Serum

Indexed keywords

BIOLOGICAL MARKER; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOSIDE GM3; GLYCAN; GLYCOSPHINGOLIPID; GLYCOPROTEIN; POLYSACCHARIDE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BLOTTING; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GLYCOBIOLOGY; GLYCOBLOTTING; HUMAN; HUMAN TISSUE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; OCCIPITAL CORTEX; PARIETAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; TEMPORAL CORTEX; VERY ELDERLY; BLOOD; BRAIN CORTEX; CEREBROSPINAL FLUID; METABOLISM; PROCEDURES;

ALZHEIMER DISEASE; BIOMARKERS; CEREBRAL CORTEX; FEMALE; GLYCOMICS; GLYCOPROTEINS; GLYCOSPHINGOLIPIDS; HUMANS; MALE; POLYSACCHARIDES;

EID: 84962826217     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2016.03.009     Document Type: Article

References (51)

1. Q.X. Li, S.J. Fuller, K. Beyreuther, and C.L. Master The amyloid precursor protein of Alzheimer's disease in human brain and blood J. Leukoc. Biol. 66 1999 567 574
2. T. Mutoh, Y. Hirabayashi, T. Mihara, M. Ueda, H. Koga, A. Ueda, T. Kokura, and H. Yamamoto Role of glycosphingolipids and therapeutic perspectives on Alzheimer's disease CNS Neurol. Disord. Drug Targets 5 2010 375 380
3. T. Arendt, V. Bigl, A. Arendt, and A. Tennstedt Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease Acta Neuropathol. 61 1983 101 108
4. D.J. Selkoe Normal and abnormal biology of the β-amyyloid precursor protein Annu. Rev. Neurosci. 17 1994 489 517
5. L.L. Iversen, R.J. Mortishire-Smith, S.J. Pollack, and M.S. Shearman The toxicity in vitro of beta-amyloid protein Biochem. J. 311 1995 1 16
6. P. Seubert, C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schlossmacher, J. Whaley, C. Swindleshurst, R. McCormack, R. Wolfert, D. Selkoe, I. Lieberburg, and D. Schenk Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids Nature 359 1992 325 327
7. M.D. Cárdenas-Aguayo, L. Gómez-Virgilio, S. DeRosa, M.A. Meraz-Ríos, The Role of Tau oligomers in the onset of Alzheimer's disease neuropathology. ACS Chem. Neurosci. (Article ASAP, DOI: 10.1021/cn500148z).
8. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide Nat. Rev. Mol. Cell Biol. 8 2007 101 112
9. R. Barone, L. Sturiale, A. Palmigiano, M. Zappia, and D. Garozzo Glycomics of pediatric and adulthood diseases of the central nervous system J. Proteome 75 2012 5123 5139
10. S.-I. Nishimura, K. Niikura, M. Kurogochi, T. Masushita, M. Fumoto, H. Hinou, R. Kamitani, H. Nakagawa, K. Deguchi, N. Miura, K. Monde, and H. Konde High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectroscopy Angew. Chem. Int. Ed. 44 2005 91 96
11. Y. Miura, M. Hato, Y. Shinohara, H. Kuramoto, J.-i. Furukawa, M. Kurogochi, H. Shimaoka, M. Tada, K. Nakanishi, M. Ozaki, S. Todo, and S.-I. Nishimura BlotGlycoABC™, an integrated glycoblotting technique for rapid and large scale clinical glycomics Mol. Cell. Proteomics 7 2008 370 377
12. J.I. Furukawa, Y. Shinohara, H. Kuramoto, Y. Miura, H. Shimaoka, M. Kurogochi, M. Nakano, and S.-.I. Nishimura Comprehensive approach to structural and functional glycomics based on chemoselective glycoblotting and sequential tag conversion Anal. Chem. 80 2008 1094 1101
13. S.-I. Nishimura Toward automated glycan analysis Adv. Carbohydr. Chem. Biochem. 65 2011 219 271
14. T. Kamiyama, H. Yokoo, J.I. Furukawa, M. Kurogochi, T. Togashi, N. Miura, K. Nakanishi, H. Kamachi, T. Kakisaka, Y. Tsuruga, A. Taketomi, S.-I. Nishimura, and S. Todo Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis Hepatology 57 2013 2314 2325
15. K. Miyahara, K. Nouso, Y. Miyake, S. Nakamura, S. Obi, M. Amano, K. Hirose, S.-I. Nishimura, and K. Yamamoto Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib Hepatology 59 2014 355 356
16. K. Nouso, M. Amano, K. Miyahara, M.I. Ito, Y. Morimoto, H. Kato, K. Tsutsumi, T. Tomoda, N. Yamamoto, S. Nakamura, S. Kobayashi, K. Kuwaki, H. Hagihara, H. Onishi, Y. Miyake, F. Ikeda, H. Shiraha, A. Takaki, T. Nakahara, S.I. Nishimura, and K. Yamamoto Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer J. Gastroenterol. 48 2013 1171 1179
17. S. Hatakeyama, M. Amano, Y. Tobisawa, T. Yoneyama, N. Tsuchiya, T. Habuchi, S.I. Nishimura, and C. Ohyama Serum N-glycan alteration associated with renal cell carcinoma detected by high-throughput glycan analysis J. Urol. 191 2014 805 813
18. Y. Ishibashi, Y. Tobisawa, S. Hatakeyama, T. Ohashi, M. Tanaka, S. Narita, T. Koike, T. Habuchi, S.I. Nishimura, C. Oyama, and T. Yoneyama Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer Prostate 74 2014 1521 1529
19. A. Urita, T. Matsuhashi, T. Onodera, H. Nakagawa, M. Hato, M. Amano, N. Seito, A. Minami, S.I. Nishimura, and N. Iwasaki Alterations of high-mannose type N-glycosylation in human and mouse osteoarthritis cartilage Arthritis Rheumatol. 63 2011 3428 3438
20. T. Ishihara, K. Kakiya, K. Takahashi, H. Miwa, M. Rokushima, T. Yoshinaga, T. Tanaka, T. Togame, H. Takemoto, M. Amano, N. Iwasaki, A. Minami, and S.I. Nishimura Discovery of novel differentiation markers in the early stage of chondrogenesis by glycoform-focused reverse proteomics and genomics Biochim. Biophys. Acta 1840 2014 645 655
21. K. Miyahara, K. Nouso, S. Saito, S. Hiraoka, K. Harada, S. Takahashi, Y. Morimoto, S. Kobayashi, F. Ikeda, Y. Miyake, H. Shiraha, A. Takaki, M. Amano, S.I. Nishimura, and K. Yamamoto Serum glycan markers for evaluation of disease activity and prediction of clinical course in patients with ulcerative colitis PLoS One 8 2013 e74861
22. Y. Yamasaki, K. Nouso, K. Miyahara, N. Wada, C. Dohi, Y. Morimoto, Y. Takeuchi, T. Yasunaka, K. Kuwaki, H. Onishi, F. Ikeda, Y. Miyake, S.I. Nakamura, H. Shiraha, A. Takaki, M. Amano, S.I. Nishimura, and K. Yamamoto Use of noninvasive serum glycan markers to distinguish nonalcoholic steatohepatitis from simple steatosis J. Gastoentol. Hepatol. 30 2015 528 534
23. S. Inafuku, K. Noda, M. Amano, M. Murata, W. Saito, T. Ohashi, A. Kanda, S.I. Nishimura, and S. Ishida Alteration of N-glycan profiles in diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 2016 in press
24. S. Inafuku, K. Noda, M. Amano, S.I. Nishimura, and S. Ishida Increase of sialylated N-glycans in eyes with neovascular glaucoma secondary to proliferative diabetic retinopathy Curr. Eye Res. 2016 in press
25. S.T. Gizaw, T. Koda, M. Amano, K. Kamimura, T. Ohashi, H. Hinou, and S.I. Nishimura A ccomprehensive glycome profiling of Huntington's disease transgenic mice Biochim. Biophys. Acta 1850 2015 1704 1718
26. M. Amano, M. Yamaguchi, Y. Takegawa, T. Yamashita, M. Terashima, J.-i. Furukawa, Y. Miura, Y. Shinohara, N. Iwasaki, A. Minami, and S.I. Nishimura Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell proliferation Mol. Cell. Proteomics 9 2010 523 537
27. N. Nagahori, T. Yamashita, M. Amano, and S.-.I. Nishimura Effect of ganglioside GM3 synthase gene knockout on the glycoprotein N-glycan profile of mouse emblionic fibroblast Chembiochem 14 2013 73 82
28. W.S. Jackson Selective vulnerability to neurodegenerative disease: the curious case of prion protein Dis. Model. Mech. 7 2014 21 29
29. C.A. Ross, and M.A. Poirier Protein aggregation and neurodegenerative disease Nat. Med. 10 2004 S10 S17
30. J. Jaeken Congenital disorders of glycosylation (CDG): it's all in it! J. Inherit. Metab. Dis. 34 2011 853 858
31. M. Citron, T. Oltersdorf, C. Haass, L. McConlogue, A.Y. Hung, P. Seubert, C. Vigo-Pelfrey, I. Lieberburg, and D.J. Selkoe Mutations of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production Nature 360 1992 672 674
32. K. Akasaka-Manya, H. Manya, Y. Sakurai, B.S. Wojczyk, S.L. Spitalnik, and T. Endo Increased bisecting and core-fucosylated N-glycans on mutant human amyloid precursor proteins Glycoconj. J. 25 2008 775 786
33. P.M. Rudd, T. Endo, C. Colominas, D. Groth, S.F. Wheeler, D.J. Harvey, M.R. Wormald, H. Serban, S.B. Prusiner, A. Kobata, and R.A. Dwek Glycosylation difference between normal and pathogenic prion protein isoforms Proc. Natl. Acad. Sci. U. S. A. 96 1999 13044 13049
34. R. Spector, and C.E. Johanson The mammalian choroid plexus Sci. Am. 261 1989 68 74
35. H. Tumani, C. Teunissen, S. Süssmuth, M. Otto, A.C. Ludolph, and J. Brettschneider Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases Expert. Rev. Mol. Diagn. 479-94 2008
36. J.L. Stanta, R. Saldova, W.B. Struwe, J.C. Byrne, F.M. Leweke, M. Rothermund, H. Rahmoune, Y. Levin, P.C. Guest, S. Bahn, and P.M. Rudd Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia J. Proteome Res. 9 2010 4476 4489
37. A. Fogli, C. Merle, V. Roussel, R. Schiffmann, S. Ughetto, M. Theisen, and O. Boespflug-Tanguy CSF N-glycan profiles to investigate biomarkers in brain developmental disorders: application to leukodystrophies related to eIF2B mutations PLoS One 7 2012 e42688
38. S. Futakawa, K. Nara, M. Miyajima, A. Kuno, H. Ito, H. Kaji, K. Shirotani, T. Honda, Y. Tohyama, K. Hoshi, Y. Hanzawa, S. Kitazume, R. Imamaki, K. Furukawa, K. Tasaki, H. Arai, T. Yuasa, M. Abe, H. Arai, H. Narimatsu, and Y. Hashimoto A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH Neurobiol. Aging 33 2012 1807 1815
39. A. Hoffmann, M. Nimtz, R. Getzlaff, and H.S. Conradt 'Brain-type' N-glycosylation of asialo-transferrin from human cerebrospinal fluid FEBS Lett. 359 1995 164 168
40. S. Zamze, D.J. Harvey, P. Pesheva, T.S. Mattu, M. Schachner, R.A. Dwek, and D.R. Wing Glycosylaton of a CNS-specific extracellular matrix glycoprotein, tenascin-R, is dominated by O-linked sialylated glycans and "brain-type" neutral N-glycans Glycobiology 9 1999 823 831
41. M. Taniguchi, Y. Okayama, Y. Hashimoto, M. Kitaura, D. Jimbo, Y. Wakutani, K. Wada-Isoe, K. Nakashima, H. Akatsu, K. Furukawa, H. Arai, and K. Urakami Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease Dement. Geriatr. Cogn. Disord. 26 2008 117 122
42. G. Ashwell, and J. Harford Carbohydrate-specific receptors in the liver Annu. Rev. Biochem. 51 1982 531 554
43. G. Chen, Y. Wang, L. Qiu, X. Qin, H. Liu, X. Wang, Y. Wang, G. Song, F. Li, Y. Guo, F. Li, S. Guo, and Z. Li Human Ig G Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer J. Proteome 75 2012 2824 2834
44. S. Bekesova, O. Kosti, K.B. Chandler, J. Wu, H.L. Madej, K.C. Brown, V. Simonyan, and R. Goldman N-glycans in liver-secreted and immunoglobulin-derived protein fractions J. Proteome 75 2012 2216 2224
45. L. Riboni, S. Sonnino, D. Acquotti, A. Malesci, R. Ghidoni, H. Egge, S. Mingrino, and G. Tettamanti Natural occurrence of ganglioside lactones. Isolation and characterization of GD1b inner ester from adult human brain J. Biol. Chem. 261 1986 8514 8519
46. M. Malander-Melin, K. Blennow, N. Bogdanovic, B. Dellheden, J.E. Mansson, and P. Fredman Structural membrane alteration in Alzheimer brain found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains J. Neurochem. 92 2005 171 182
47. I. Kracun, S. Kalanj, J. Talan-Hranilovic, and C. Cosovic Cortical distribution of gangliosides in Alzheimer's disease Neurochem. Int. 20 1992 433 438
48. S. Kalanj, I. Kracun, H. Rosner, and C. Cosovic Regional distribution of brain gangliosides in Alzheimer's disease Neurol. Croat. 40 1991 269 281
49. T. Ariga, C. Wakade, and R.K. Yu The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neruogenesis Int. J. Alzheimer's Dis. 193618 2011
50. T. Ariga, M.P. McDonald, and R.K. Yu Role of gangliosides metabolism in the pathogenesis of Alzheimer's disease - a review J. Lipid Res. 49 2008 1157 1175
51. A.J. Farrall, and J.M. Wardlaw Blood-brain barrier: ageing and micorvascular disease-systematic review and meta-analysis Neurobiol. Aging 30 2009 337 352